Journal of Clinical Endocrinology & Metabolism, Vol 70, 173-180, Copyright © 1990 by Endocrine Society

ARTICLES

The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro

WM Burch, J Correa, JE Shively and DR Powell
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Insulin-like growth factor (IGF)-I stimulates the growth of many tissues, including growth plate cartilage. However, the role of IGF- binding proteins in the growth process is controversial. We purified a 25-kDa IGF-binding protein (BP-25) from amniotic fluid. We tested the effect of this BP-25 preparation on both basal and IGF-I-stimulated growth of chick embryo pelvic cartilages maintained in serum-free organ culture. Cartilage wet weight was 4.1 +/- 0.3 mg/cartilage initially; after 3 days, BP-25 inhibited both basal and IGF-I-stimulated growth. Control cartilages weighed 7.4 +/- 0.7 mg/cartilage, while those incubated with 100 nM BP-25 weighed 5.8 +/- 0.5 mg/cartilage (P less than 0.001 vs. control); BP-25 concentrations as low as 0.2 nM significantly inhibited basal cartilage growth. Cartilages incubated with 1.25 nM IGF-I weighed 10.4 +/- 0.8 mg/cartilage (P less than 0.001 vs. control), while those incubated with both 100 nM BP-25 and 1.25 nM IGF-I weighed 8.1 +/- 0.5 mg/cartilage (P less than 0.001 vs. cartilage incubated with IGF-I alone); BP-25 concentrations as low as 0.4 nM significantly inhibited IGF-I-stimulated cartilage growth. BP-25 also inhibited basal and IGF-I-stimulated increases in cartilage dry weight, [3H]thymidine incorporation into DNA, and 35SO4 incorporation into proteoglycan. A second BP-25 preparation, which in the presence of 1% platelet-poor plasma acts synergistically with IGF-I to stimulate DNA synthesis and cell replication of fibroblasts and smooth muscle cells in tissue culture, inhibited IGF-I-stimulated cartilage growth to the same degree as did our BP-25 preparation. In separate experiments, proteins present in serum-free medium conditioned for 3 days by chick cartilages were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and incubated with [125I]IGF-I. This medium was found to contain two IGF-binding proteins; one appeared to be the chick equivalent of BP-25, while the other had a molecular mass similar to that of a poorly characterized human 34-kDa IGF-binding protein. We conclude that purified BP-25 inhibits the growth of chick embryo pelvic cartilage in our serum-free organ culture system. Since conditioned medium from these cartilages contains both IGF-I-like peptides and IGF-binding proteins such as BP-25, we suggest that the IGF-binding proteins present may act to down-regulate the growth-promoting effects of the local IGF peptides.

This article has been cited by other articles:

				M. Westwood, J. D. Aplin, I. A. Collinge, A. Gill, A. White, and J. M. Gibson alpha 2-Macroglobulin: a New Component in the Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-1 Axis J. Biol. Chem., November 2, 2001; 276(45): 41668 - 41674. [Abstract] [Full Text] [PDF]

				J. C. D. Filho, S. J. Hazel, B. Anderstam, J. Bergstrom, M. Lewitt, and K. Hall Effect of protein intake on plasma and erythrocyte free amino acids and serum IGF-I and IGFBP-1 levels in rats Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E693 - E701. [Abstract] [Full Text] [PDF]

				K. M. Kelley, T. R. Johnson, J. Ilan, and R. W. Moskowitz Glucose regulation of the IGF response system in chondrocytes: induction of an IGF-I-resistant state Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1164 - R1171. [Abstract] [Full Text] [PDF]

				D. R. Powell, S. K. Durham, E. D. Brewer, J. W. Frane, S. L. Watkins, R. J. Hogg, and S. Mohan Effects of Chronic Renal Failure and Growth Hormone on Serum Levels of Insulin-Like Growth Factor-Binding Protein-4 (IGFBP-4) and IGFBP-5 in Children: A Report of the Southwest Pediatric Nephrology Study Group J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 596 - 601. [Abstract] [Full Text]

				P. G. Campbell, S. K. Durham, A. Suwanichkul, J. D. Hayes, and D. R. Powell Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3 Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E321 - E331. [Abstract] [Full Text] [PDF]

				D. Sunic, J. D. McNeil, T. E. Rayner, D. L. Andress, and D. A. Belford Regulation of Insulin-Like Growth Factor-Binding Protein-5 by Insulin-Like Growth Factor I and Interleukin-1{alpha} in Ovine Articular Chondrocytes Endocrinology, May 1, 1998; 139(5): 2356 - 2362. [Abstract] [Full Text] [PDF]

				D. Haffner, W. F. Blum, U. Heinrich, O. Mehls, and B. Tonshoff Impaired Postprandial Regulation of Insulin-Like Growth Factor Binding Protein-1 in Children with Chronic Renal Failure J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2832 - 2835. [Abstract] [Full Text] [PDF]

				D. R. Powell, F. Liu, B. K. Baker, R. L. Hintz, S. K. Durham, E. D. Brewer, J. W. Frane, B. Tonshoff, O. Mehls, A.-M. Wingen, et al. Insulin-Like Growth Factor-Binding Protein-6 Levels Are Elevated in Serum of Children with Chronic Renal Failure: A Report of the Southwest Pediatric Nephrology Study Group J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2978 - 2984. [Abstract] [Full Text] [PDF]

				A. M. Mirza, S. Ezzat, and A. A. Axelrad Insulin-Like Growth Factor Binding Protein-1 Is Elevated in Patients With Polycythemia Vera and Stimulates Erythroid Burst Formation In Vitro Blood, March 15, 1997; 89(6): 1862 - 1869. [Abstract] [Full Text] [PDF]

				K. Sakai, W. H. Busby Jr., J. B. Clarke, and D. R. Clemmons Tissue Transglutaminase Facilitates the Polymerization of Insulin-like Growth Factor-binding Protein-1 (IGFBP-1) and Leads to Loss of IGFBP-1's Ability to Inhibit Insulin-like Growth Factor-I-stimulated Protein Synthesis J. Biol. Chem., March 16, 2001; 276(12): 8740 - 8745. [Abstract] [Full Text] [PDF]